罗德的干预措施应解决与耻辱相关的障碍,以改善年轻的RA患者的坚持
Yuying Qian1, Minli Liu2, Jian Sun2
1Department of Wuxi Medical College, Jiangnan University, Wuxi, Jiangsu, China.
Psychology, health & medicine
|May 9, 2025
概括
耻辱感显著影响类风湿性关节炎 (RA) 患者的药物坚持,特别是年轻人. 针对性干预解决耻辱是改善RA治疗坚持在这些年龄组至关重要的.
科学领域:
- 类风湿病学 类风湿病学
- 慢性疾病的心理社会方面
背景情况:
- 类风湿性关节炎 (RA) 管理需要持续服药.
- 与慢性疾病相关的耻辱感可能会对患者的治疗结果产生负面影响.
- 了解与年龄相关的污名对RA患者影响的差异是必不可少的.
研究的目的:
- 调查类风湿性关节炎患者的耻辱和药物坚持之间的关系.
- 检查不同年龄组如何感知和受到污名的影响.
- 为了确定年龄特定的因素,影响RA药物的坚持.
主要方法:
- 一项涉及250名18岁以上RA患者的横截面研究.
- 使用了慢性疾病的耻辱度表 (SSCI) 和8项药物坚持度表 (MMAS-8).
- 进行了分层线性回归分析,以分析跨年龄人口统计数据.
主要成果:
- 在不同年龄组中观察到污名度的显著变化 (P<0.05).
- 年龄组之间没有发现药物坚持的显著差异.
- 耻辱症在18-44岁和45-59岁的年龄段对药物坚持有显著的负面影响 (P<0.05).
结论:
- 耻辱感是类风湿性关节炎中药物坚持的重要障碍,特别是在年轻的成年患者中.
- 旨在减少耻辱的干预措施是必要的,以改善RA的治疗坚持.
- 未来的研究应该专注于为年轻的RA人群制定定制的,减少耻辱的策略.
相关概念视频
Stress Prevention and Stress Management Techniques VI
21
Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
21
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
241
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
241
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Drugs Used in Lower Respiratory Disorders: Overview
247
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
247


